Sulfuric Acid

Sulfuric Acid

SCHEMBL781963

CCCCCCCC[N+](C)(CCCCCCCC)CCCCCCCC.O=S(=O)([O-])O

nearest known ligand 0.48

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

CYP51cyp51Acyp51c

The experimentally established mechanism targets of Sulfuric Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 8)

geneUniProtsupporting neighboursconfidence
LSS P48449 1/20 0.48
DNM1 Q05193 11/20 0.46
HTT P42858 2/20 0.46
SLC22A1 O15245 1/20 0.44
KMT2A Q03164 1/20 0.43
APAF1 O14727 1/20 0.43
HSP90AA1 P07900 1/20 0.43
RAD52 P43351 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Sulfuric Acid SCHEMBL6054968 1.00 LSS (0.48) LSSDNM1HTTSLC22A1KMT2A
Sulfuric Acid SCHEMBL6257863 1.00 LSS (0.48) LSSDNM1HTTSLC22A1KMT2A
Sulfuric Acid SCHEMBL6261099 1.00 LSS (0.48) LSSDNM1HTTSLC22A1KMT2A
Sulfuric Acid SCHEMBL2544115 1.00 LSS (0.48) LSSDNM1HTTSLC22A1KMT2A
Sulfuric Acid SCHEMBL6405441 1.00 LSS (0.48) LSSDNM1HTTSLC22A1KMT2A
Sulfuric Acid SCHEMBL28797975 0.94 LSS (0.43) LSSDNM1HTTSLC22A1KMT2A
Tetrabuthylammonium SCHEMBL11187336 0.92 SLC22A1 (0.48) LSSDNM1SLC22A1
Sulfuric Acid SCHEMBL9358660 0.92 DNM1 (0.45) LSSDNM1HTTSLC22A1KMT2A
Sulfuric Acid SCHEMBL2995826 0.91 LSS (0.52) LSSDNM1HTTSLC22A1KMT2A
Sulfuric Acid SCHEMBL4151447 0.91 LSS (0.52) LSSDNM1HTTSLC22A1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 289 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4739658-A1 SYNTHESIS OF PYRUVATE KINASE ACTIVATORS Agios Pharmaceuticals, Inc. (US) 2026-05-13 EP claimed
EP-4658652-A2 PROCESSES AND INTERMEDIATES FOR SYNTHESIS OF ADAGRASIB Mirati Therapeutics, Inc. (US) 2025-12-10 EP claimed
WO-2025229195-A1 RADIOLABELLED COMPOUNDS IMPERIAL COLLEGE INNOVATIONS LIMITED (GB) 2025-11-06 WO claimed
US-20250043039-A1 HALOGEN RECOVERY WITH OXIDANT AND PHASE TRANSFER CATALYST IN A PROCESS FOR HALOGENATING UNSATURATED ISOOLEFIN COPOLYMER ARLANXEO SINGAPORE PTE. LTD. (SG) 2025-02-06 US claimed
WO-2025020462-A1 PREPARATION METHOD FOR CHIRAL DIHYDROTHIENOPYRIMIDINE SULFOXIDE AND USE THEREOF, AND 2- AND 4-SUBSTITUTED COMPOUND OF CHIRAL DIHYDROTHIENOPYRIMIDINE SULFOXIDE 厦门大学 2025-01-30 WO claimed
WO-2025010390-A1 SYNTHESIS OF PYRUVATE KINASE ACTIVATORS AGIOS PHARMACEUTICALS, INC. (US) 2025-01-09 WO claimed
CN-119072477-A Process and intermediates for the synthesis of adaglazeb 米拉蒂治疗股份有限公司 2024-12-03 CN claimed
CN-113754570-B Synthesis method of 2-propionitrile sulfonyl acetonitrile 河北圣泰材料股份有限公司 2024-10-25 CN claimed
EP-4448595-A1 HALOGEN RECOVERY WITH OXIDANT AND PHASE TRANSFER CATALYST IN A PROCESS FOR HALOGENATING UNSATURATED ISOOLEFIN COPOLYMER Arlanxeo Singapore Pte. Ltd. (SG) 2024-10-23 EP claimed
WO-2024209278-A1 A PROCESS FOR THE PREPARATION OF PYROXASULFONE GHARDA CHEMICALS LIMITED (IN) 2024-10-10 WO claimed
US-7696366-B2 Production process of bifunctional epoxy monomer by selective oxidation of diolefin compound SHOWA DENKO K.K. (JP) 2010-04-13 US claimed
US-7541312-B2 Porous carbons from carbohydrates TDA RESEARCH, INC. (US) 2009-06-02 US claimed
US-20090112017-A1 METHOD FOR PRODUCING POLYISOCYANATES BASF AKTIENGESSELLSCHAFT (DE) 2009-04-30 US claimed
EP-1725497-A4 POROUS CARBONS FROM CARBOHYDRATES TDA RESEARCH INC (US) 2008-11-05 EP claimed
EP-1725497-A2 POROUS CARBONS FROM CARBOHYDRATES TDA RESEARCH, INC. (US) 2006-11-29 EP claimed
US-20060216828-A1 Rapid-response reversible dry surface CO2 detector MERCURY ENTERPRISE, INC. 2006-09-28 US claimed
WO-2005089145-A2 POROUS CARBONS FROM CARBOHYDRATES TDA RESEARCH, INC. (US) 2005-09-29 WO claimed
US-20050207962-A1 Porous carbons from carbohydrates TDA RESEARCH, INC. (US) 2005-09-22 US claimed
US-20050208248-A1 Automotive fuel hose and method for producing the same TOKAI RUBBER INDUSTRIES, LTD. (JP) 2005-09-22 US claimed
US-5578719-A Sulphonated derivatives of cyclomalto-oligosaccharides, their preparation process and support for active substances containing these derivatives COMMISSARIAT A L'ENERGIE ATOMIQUE (FR) 1996-11-26 US claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090112017-A1 METHOD FOR PRODUCING POLYISOCYANATES PGLS, INMT, PNMT LSS 21/4885DNM1 3850/4885HTT 1805/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.